Virtual Show: Syntegon Technology showcases expertise for producing and processing liquid pharmaceuticals
Summary
Based on digital machine presentations, concept studies and pilot projects as well as numerous opportunities to contact the experts, Syntegon shows how pharmaceutical manufacturers can prepare for future trends: new, targeted drugs for small patient groups require greater flexibility in the configuration of filling lines. "The individually configurable, modular machine concept for processing small and medium batches is the answer to the increasing demand for drugs for smaller target groups, for example in the treatment of cancer," explains Klaus Ullherr, senior product manager at Syntegon. "The monobloc solution combines all the advantages of linear filling with rotary capping technology and fulfils the high demand in the medium output segment from 80 to 150 bpm," says Frank Jansen, head of product management at Syntegon. "Until now, object-specific data could no longer be assigned to individual batches or containers as soon as they left the machine," Markus Heinz, product manager at Syntegon, explains. In contrast to many other industries, the deep learning model in pharmaceutical use must be statically fixed after the development phase and is not allowed to change in order to meet the corresponding validation requirements.